Medicover plans Skr2bn diagnostic services IPO

By Aidan Gregory
02 May 2017

Medicover, the Swedish diagnostic services provider, on Tuesday joined the growing number of European companies seeking to go public before the summer, announcing its intention to float on Nasdaq Stockholm.

Jefferies and SEB are global co-ordinators, Carnegie and Nordea bookrunners.

The company will raise around Skr2bn (€210m) to finance its growth strategy by selling new B shares to institutional investors, and to retail investors in Sweden.

Medicover is 94% owned by Celox Holding, R12 Kapital Fund ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.